How best to structure a laboratory network with new technologies by Dr Cristina Gutierrez

The rational for introducing new TB tests in a network

Disease burden, size of the country, level of decentralization

Eligible patient to be tested and diagnostic algorithm

  • Smear positive and/ or negative
  • Any case or only any drug resistant suspect or only MDR suspects
  • Low and high HIV settings
  • Low and high MDR settings

Specimen/patient referral

Linkage to treatment

Costs and donors support

Technical realities and implementation challenges